Forskning ved Københavns Universitet - Københavns Universitet


Report of the international conference on manufacturing and testing of pluripotent stem cells

Publikation: Bidrag til tidsskriftKonferenceartikelForskningfagfællebedømt

  • Stewart Abbot
  • Francisca Agbanyo
  • Jan-Eric Ahlfors
  • Behnam A. Baghbaderani
  • Shirley Bartido
  • Kapil Bharti
  • Carl Burke
  • Bjorn Carlsson
  • Joy Cavagnaro
  • Abla Creasey
  • Stephen Lin
  • David DiGiusto
  • Kathy Francissen
  • Andrew Gaffney
  • Christopher Goldring
  • Thorsten Gorba
  • Elwyn Griffiths
  • Anthony Lubiniecki
  • Joris Vandeputte
  • Tadaaki Hanatani
  • Takao Hayakawa
  • Tatsuo Heki
  • Karin Hoogendoorn
  • Shin Kawamata
  • Hironobu Kimura
  • Ivana Knezevic
  • Jane Lebkowski
  • Shen Lin-Gibson
  • Orla O'Shea
  • Martin Pera
  • John Petricciani
  • Gary Pigeau
  • Anthony Ratcliffe
  • Yoji Sato
  • Gerald G. Schumann
  • William Shingleton
  • Chair Glyn Stacey
  • Stephen Sullivan
  • Clive N. Svendsen
  • Jean-Hugues Trouvin
  • Bao-Zhu Yuan
  • Kathryn Zoon
Sessions included an overview of past cell therapy (CT) conferences sponsored by the International Alliance for Biological Standardization (IABS). The sessions highlighted challenges in the field of human pluripotent stem cells (hPSCs) and also addressed specific points on manufacturing, bioanalytics and comparability, tumorigenicity testing, storage, and shipping. Panel discussions complemented the presentations. The conference concluded that a range of new standardization groups is emerging that could help the field, but ways must be found to ensure that these efforts are coordinated. In addition, there are opportunities for regulatory convergence starting with a gap analysis of existing guidelines to determine what might be missing and what issues might be creating divergence. More specific global regulatory guidance, preferably from WHO, would be welcome. IABS and the California Institute for Regenerative Medicine (CIRM) will explore with stakeholders the development of a practical and innovative road map to support early CT product (CTP) developers.[on SciFinder (R)]
Sider (fra-til)67-83
StatusUdgivet - nov. 2018
BegivenhedManufacturing and Testing of Pluripotent Stem Cells: IABS and CIRM - Los Angeles, USA
Varighed: 5 jun. 20186 jun. 2018


KonferenceManufacturing and Testing of Pluripotent Stem Cells
ByLos Angeles

ID: 202078718